Sources

Homepage

IQVIA Institute for Human Data Science, “Medicines Use and Spending in the U.S.: Review of 2017 and Outlook to 2022,” April 2017. Adjusted based on prescription length.

AHIP Center for Policy and Research. “Where does your premium dollar go?” March 2, 2017 https://www.ahip.org/health-care-dollar/

2 Express Scripts, “U.S. Rx Spending Increased 13.1% in 2014,” March 2015 and “2017 Drug Trend Report,” February 2018.

3 IQVIA Institute for Human Data Science, “Medicines Use and Spending in the U.S.: Review of 2017 and Outlook to 2022,” April 2017. Includes programs in Phase 2 through Registered with activity in the past three years.

Pharmacy Benefit Management Institute, “2018 Trends in Specialty Drug Benefits,” 2018. Based on survey of 299 respondents who manage the drug benefit for their organization.

5 Pembroke Consulting and IQVIA Institute for Human Data Science, May 2017.

6 Diplomat Pharmacy Inc., “Specialty Drug Approvals: 2017 Highlights & 2018 Projections,” February 2018. Approximate.

Why Choose CastiaRx

7 Diplomat Patient Surveys, 2017. Data from third-party survey. Reflects approximate percentage of respondents selecting “excellent,” “very good,” or “good” on a five-point scale.

8 Diplomat Specialty Pharmacy Adherence Reporting, 2017. Approximate. Average capped medication possession ratio. Includes patients with at least two fills and no 60-plus-day gaps between fills. Does not include Diplomat Specialty Infusion Group.